Russell Schundler serves as the General Counsel and Secretary at LIQUIDIA CORP, a biopharmaceutical company focused on developing and commercializing novel products via its proprietary PRINT technology. In his role, Schundler is responsible for overseeing the company's legal affairs, ensuring compliance with regulations, and providing strategic guidance to the executive team. His expertise in the legal aspects of the pharmaceutical industry has been instrumental in navigating the complex landscape of drug development and commercialization. Prior to joining LIQUIDIA CORP, Schundler held several high-profile positions in the legal field. He began his career at a prestigious law firm, where he specialized in intellectual property law and gained extensive experience in patent litigation and licensing. Schundler's deep understanding of the intricacies of IP law has been a valuable asset to LIQUIDIA CORP, particularly in protecting the company's innovative technologies and securing its competitive edge in the market. Throughout his career, he has been recognized for his ability to provide sound legal counsel while also driving business growth and innovation. Schundler's achievements extend beyond his professional accomplishments. He is an active member of several industry associations and has been invited to speak at numerous conferences on topics related to intellectual property and the pharmaceutical industry. His thought leadership and commitment to advancing the field have earned him respect among his peers. At LIQUIDIA CORP, Schundler continues to play a crucial role in shaping the company's legal strategy and supporting its mission to bring life-changing therapies to patients worldwide.